EUVIMEDEUVIMED entdecken
Crossref

A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells

Jiahao Liu, Long Wang, Yongbo Peng, Shuyang Long, Hongliang Zeng, Minhua Deng, Wei Xiang, Biao Liu, Xing Hu, Xuewen Liu, Jianfei Xie, Weibin Hou und 2 weitere

Biomaterials Science · 2025

DOI: 10.1039/d4bm01471e ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2025. Verfasst von Jiahao Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Xiangya Hospital of Central South University, No. 138, Tongzipo Road, Changsha, 410013, Hunan, China. 602536@csu.edu…. Hauptthemen laut MEDLINE: Epithelial Cell Adhesion Molecule, Urinary Bladder Neoplasms, Aptamers, Nucleotide, Deoxycytidine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Basic Research Program of China, Natural Science Foundation of Hunan Province, Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schematic diagram of the synthesis of EpCAM-GEMs and their role in cells (bladder cancer cells and bladder cancer stem cells).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial Cell Adhesion MoleculeUrinary Bladder NeoplasmsAptamers, NucleotideDeoxycytidineNeoplastic Stem CellsGemcitabineAnimalsHumansMiceCell Line, TumorApoptosisXenograft Model Antitumor AssaysMice, NudeCell ProliferationMice, Inbred BALB C

Substanzen

Epithelial Cell Adhesion MoleculeAptamers, NucleotideDeoxycytidineGemcitabineEPCAM protein, human

Autor:innen und Institutionen

  • Department of Urology, The Third Xiangya Hospital of Central South University, No. 138, Tongzipo Road, Changsha, 410013, Hunan, China. 602536@csu.edu.cn.
  • Chongqing Key Laboratory for Pharmaceutical Metabolism Research, College of Pharmacy, Chongqing Medical University, No. 1, Yixueyuan Road, Chongqing, 400016, China.
  • School of Medicine, Hunan University of Chinese Medicine, Grade 2024, China.
  • Institute of Chinese Materia Medica, Hunan Academy of Chinese Medicine, No. 8, Yuehua Road, Changsha 410013, China.
  • Department of Urology, Sun Yat-sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
  • State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, No. 651, Dongfeng Road East, Guangzhou, 510060, Guangdong, China.

Förderung

  • National Basic Research Program of China
  • Natural Science Foundation of Hunan Province
  • Central South University

Zitieren

APA

Liu, J., Wang, L., Peng, Y., Long, S., Zeng, H., Deng, M., Xiang, W., Liu, B., Hu, X., Liu, X., Xie, J., Hou, W., Tang, J., & Liu, J. (2025). A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells. Biomaterials Science. https://doi.org/10.1039/d4bm01471e

Vancouver

Liu J, Wang L, Peng Y, Long S, Zeng H, Deng M, et al. A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells. Biomaterials Science. 2025. doi:10.1039/d4bm01471e

BibTeX
@article{Liu2025,
  author = {Liu, Jiahao and Wang, Long and Peng, Yongbo and Long, Shuyang and Zeng, Hongliang and Deng, Minhua and Xiang, Wei and Liu, Biao and Hu, Xing and Liu, Xuewen and Xie, Jianfei and Hou, Weibin and Tang, Jin and Liu, Jianye},
  title = {A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells},
  journal = {Biomaterials Science},
  year = {2025},
  doi = {10.1039/d4bm01471e}
}
Kostenlos starten →